National Health Investors Inc (NHI)
Official siteREAL ESTATE • REIT - HEALTHCARE FACILITIES • NYSE
Market Cap: $3.09B
Last updated: Nov 17, 2026 at 11:06 AM ET
National Health Investors Inc (NHI) P/E Ratio & Valuation History
National Health Investors (NHI) trades at 12.2x its 2026 FFO estimate. Its forward P/E is 18.1x. It trades at 6.5x sales and 1.4x book value. Its P/S is below its 5-year median of 9.0x.
Current Multiples
Its P/FFO of 12.2x uses the 2026 FFO estimate of $4.96 per share. Its enterprise value is 4.5x its EBITDA.
| Multiple | Value |
|---|---|
| P/FFO (2026 estimate) | 12.2x |
| P/E (trailing) | 14.1x |
| Forward P/E | 18.1x |
| Price to sales | 6.5x |
| Price to book | 1.4x |
| EV/EBITDA | 4.5x |
| PEG | 4.8 |
| FCF yield | -5.3% |
Historical Medians
Against its 10-year medians, its P/E is 33.5% below 21.2x, its P/S is 31.6% below 9.5x and its P/B is 39.1% below 2.3x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 14.1x | 23.8x | 21.2x |
| P/S | 6.5x | 9.0x | 9.5x |
| P/B | 1.4x | 2.2x | 2.3x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 17.8x in 2023 to 26.6x in 2022.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $76.37 | 22.1x | 9.5x | 2.4x |
| 2024 | $69.30 | 23.3x | 9.1x | 2.3x |
| 2023 | $55.85 | 17.8x | 7.6x | 1.9x |
| 2022 | $52.22 | 26.6x | 7.6x | 1.8x |
| 2021 | $57.47 | 24.4x | 8.8x | 1.7x |
| 2020 | $69.17 | 18.6x | 9.3x | 2.1x |
| 2019 | $81.48 | 22.2x | 11.1x | 2.4x |
| 2018 | $75.54 | 20.5x | 10.8x | 2.3x |
| 2017 | $75.38 | 20.6x | 11.1x | 2.4x |
| 2016 | $74.17 | 20.9x | 11.7x | 2.5x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About NHI
What is NHI's forward P/E ratio?
National Health Investors has a forward P/E ratio of 18.1x. It trades at 12.2x its 2026 FFO estimate.
Is NHI stock overvalued?
National Health Investors trades at 12.2x its 2026 FFO estimate. GNG's valuation label for NHI is Undervalued.
What is NHI's price to sales ratio?
National Health Investors has a price to sales ratio of 6.5x.
What is National Health Investors's average P/E ratio over 5 years?
National Health Investors's median P/E over the last 5 years is 23.8x, from 60 month-end values through Oct 2026. It trades at 12.2x its 2026 FFO estimate.
What is NHI's PEG ratio?
National Health Investors has a PEG ratio of 4.8.
NHI pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors